PD-1/PD-L1 inhibitor Clinical Trials
3 recruitingDrug
Phase 11Phase 21Not Applicable1
Showing 1–3 of 3 trials
Recruiting
Not Applicable
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
Biliary Tract Cancer (BTC)
Peking University40 enrolled2 locationsNCT07466238
Recruiting
Phase 2
An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.
Biliary Tract Cancer
Peking Union Medical College Hospital300 enrolled1 locationNCT07282262
Recruiting
Phase 1
The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer
Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University8 enrolled1 locationNCT05735028